These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 29618387)
1. Deregulation of the spindle assembly checkpoint is associated with paclitaxel resistance in ovarian cancer. Chong T; Sarac A; Yao CQ; Liao L; Lyttle N; Boutros PC; Bartlett JMS; Spears M J Ovarian Res; 2018 Apr; 11(1):27. PubMed ID: 29618387 [TBL] [Abstract][Full Text] [Related]
2. Weakened spindle checkpoint with reduced BubR1 expression in paclitaxel-resistant ovarian carcinoma cell line SKOV3-TR30. Fu Y; Ye D; Chen H; Lu W; Ye F; Xie X Gynecol Oncol; 2007 Apr; 105(1):66-73. PubMed ID: 17234259 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of JAK2 Reverses Paclitaxel Resistance in Human Ovarian Cancer Cells. Xu Y; Zhang J; Wu J; Zhong S; Li H Int J Gynecol Cancer; 2015 Nov; 25(9):1557-64. PubMed ID: 26360705 [TBL] [Abstract][Full Text] [Related]
4. Boosting the apoptotic response of high-grade serous ovarian cancers with CCNE1 amplification to paclitaxel in vitro by targeting APC/C and the pro-survival protein MCL-1. Raab M; Kobayashi NF; Becker S; Kurunci-Csacsko E; Krämer A; Strebhardt K; Sanhaji M Int J Cancer; 2020 Feb; 146(4):1086-1098. PubMed ID: 31286496 [TBL] [Abstract][Full Text] [Related]
5. BRCA1 downregulation leads to premature inactivation of spindle checkpoint and confers paclitaxel resistance. Chabalier C; Lamare C; Racca C; Privat M; Valette A; Larminat F Cell Cycle; 2006 May; 5(9):1001-7. PubMed ID: 16639080 [TBL] [Abstract][Full Text] [Related]
6. Blocking Mitotic Exit of Ovarian Cancer Cells by Pharmaceutical Inhibition of the Anaphase-Promoting Complex Reduces Chromosomal Instability. Raab M; Sanhaji M; Zhou S; Rödel F; El-Balat A; Becker S; Strebhardt K Neoplasia; 2019 Apr; 21(4):363-375. PubMed ID: 30851646 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-136 inhibits cancer stem cell activity and enhances the anti-tumor effect of paclitaxel against chemoresistant ovarian cancer cells by targeting Notch3. Jeong JY; Kang H; Kim TH; Kim G; Heo JH; Kwon AY; Kim S; Jung SG; An HJ Cancer Lett; 2017 Feb; 386():168-178. PubMed ID: 27887917 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of forkhead box protein M1 (FOXM1) in ovarian cancer correlates with poor patient survival and contributes to paclitaxel resistance. Zhao F; Siu MK; Jiang L; Tam KF; Ngan HY; Le XF; Wong OG; Wong ES; Gomes AR; Bella L; Khongkow P; Lam EW; Cheung AN PLoS One; 2014; 9(11):e113478. PubMed ID: 25411964 [TBL] [Abstract][Full Text] [Related]
9. Reversal of Chemoresistance in Ovarian Cancer by Co-Delivery of a P-Glycoprotein Inhibitor and Paclitaxel in a Liposomal Platform. Zhang Y; Sriraman SK; Kenny HA; Luther E; Torchilin V; Lengyel E Mol Cancer Ther; 2016 Oct; 15(10):2282-2293. PubMed ID: 27466355 [TBL] [Abstract][Full Text] [Related]
10. Effect of spindle checkpoint on Akt2-mediated paclitaxel-resistance in A2780 ovarian cancer cells. Zhou T; Bao Y; Ye S; Weng D; Chen G; Lu Y; Ma D; Wang S J Huazhong Univ Sci Technolog Med Sci; 2010 Apr; 30(2):206-11. PubMed ID: 20407875 [TBL] [Abstract][Full Text] [Related]
11. 6,7-Dimethoxy-3-(3-methoxyphenyl)isoquinolin-1-amine induces mitotic arrest and apoptotic cell death through the activation of spindle assembly checkpoint in human cervical cancer cells. Chung KS; Choi HE; Shin JS; Cho YW; Choi JH; Cho WJ; Lee KT Carcinogenesis; 2013 Aug; 34(8):1852-60. PubMed ID: 23615402 [TBL] [Abstract][Full Text] [Related]
12. PRP4K is a HER2-regulated modifier of taxane sensitivity. Corkery DP; Le Page C; Meunier L; Provencher D; Mes-Masson AM; Dellaire G Cell Cycle; 2015; 14(7):1059-69. PubMed ID: 25602630 [TBL] [Abstract][Full Text] [Related]
13. Androgen receptor negatively regulates mitotic checkpoint signaling to induce docetaxel resistance in castration-resistant prostate cancer. Pilling A; Kim SH; Hwang C Prostate; 2022 Feb; 82(2):182-192. PubMed ID: 34672379 [TBL] [Abstract][Full Text] [Related]
14. Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells. Wen C; Chen J; Zhang D; Wang H; Che J; Qin Q; He L; Cai Z; Lin M; Lou Q; Huang L; Chen D; Iwamoto A; Ren D; Wang L; Lan P; Wang J; Liu H; Yang X Cancer Lett; 2016 Dec; 383(2):295-308. PubMed ID: 27713084 [TBL] [Abstract][Full Text] [Related]
15. Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer. Furlong F; Fitzpatrick P; O'Toole S; Phelan S; McGrogan B; Maguire A; O'Grady A; Gallagher M; Prencipe M; McGoldrick A; McGettigan P; Brennan D; Sheils O; Martin C; W Kay E; O'Leary J; McCann A J Pathol; 2012 Apr; 226(5):746-55. PubMed ID: 22069160 [TBL] [Abstract][Full Text] [Related]
16. Dependence of paclitaxel sensitivity on a functional spindle assembly checkpoint. Sudo T; Nitta M; Saya H; Ueno NT Cancer Res; 2004 Apr; 64(7):2502-8. PubMed ID: 15059905 [TBL] [Abstract][Full Text] [Related]
17. iASPP and chemoresistance in ovarian cancers: effects on paclitaxel-mediated mitotic catastrophe. Jiang L; Siu MK; Wong OG; Tam KF; Lu X; Lam EW; Ngan HY; Le XF; Wong ES; Monteiro LJ; Chan HY; Cheung AN Clin Cancer Res; 2011 Nov; 17(21):6924-33. PubMed ID: 21926165 [TBL] [Abstract][Full Text] [Related]
19. Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability. Yang H; Mao W; Rodriguez-Aguayo C; Mangala LS; Bartholomeusz G; Iles LR; Jennings NB; Ahmed AA; Sood AK; Lopez-Berestein G; Lu Z; Bast RC Clin Cancer Res; 2018 Oct; 24(20):5072-5084. PubMed ID: 30084832 [No Abstract] [Full Text] [Related]
20. HOTAIR promotes paclitaxel resistance by regulating CHEK1 in ovarian cancer. Jiang J; Wang S; Wang Z; Cai J; Han L; Xie L; Han Q; Wang W; Zhang Y; He X; Yang C Cancer Chemother Pharmacol; 2020 Aug; 86(2):295-305. PubMed ID: 32743678 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]